Mechanisms behind efficacy of tumor necrosis factor inhibitors in inflammatory bowel diseases. | Semantic Scholar
Frontiers | Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology | Immunology
Anti-TNF therapy in the injured spinal cord: Trends in Pharmacological Sciences
Molecular mechanisms of action of anti-TNF-α agents – Comparison among therapeutic TNF-α antagonists - ScienceDirect
Anti-TNF-α therapies: the next generation | Nature Reviews Drug Discovery
Biosimilars in Inflammatory Bowel Disease: Facts and Fears of Extrapolation - Clinical Gastroenterology and Hepatology
Article
Internet Scientific Publications
TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants – past, present and future - ScienceDirect
Infliximab Overview - Creative Biolabs
TNF Inhibitor - an overview | ScienceDirect Topics
Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling | Gut
Tumor Necrosis Factor-Alpha Inhibitory Therapy for Non-Infectious Autoimmune Uveitis | IntechOpen
Striking a new path – extending the diagnostic portfolio by test systems for therapeutic drug monitoring - EUROIMMUNBlog
Indication extrapolation for anti-TNF biosimilars | Nature Reviews Gastroenterology & Hepatology
IJMS | Free Full-Text | A Novel Hepatic Anti-Fibrotic Strategy Utilizing the Secretome Released from Etanercept-Synthesizing Adipose-Derived Stem Cells | HTML
Xia & He Publishing
Figure 1 | Biological Treatments in Behçet's Disease: Beyond Anti-TNF Therapy
Tumor Necrosis Factor (TNF) Inhibitors: A Clinical Primer
Tuberculosis in the era of anti-TNF-alpha therapy: Why does the risk still exist?
Gene polymorphisms that can predict response to anti-TNF therapy in patients with psoriasis and related autoimmune diseases | The Pharmacogenomics Journal
Clin. Pharm. Card: AMJEVITA – Drug and Device Digest
